CORDMILK:脐带挤奶与早断脐对出生时无活力新生儿短期和长期结局的影响——多中心、整群随机、交叉对照试验研究方案
CORDMILK试验为多中心整群随机交叉对照研究,在印度七家中心比较脐带挤奶与早断脐对出生时无活力足月及晚期早产儿的短期和长期结局。主要复合结局为出生住院期间死亡或中重度缺氧缺血性脑病(HIE),以及2岁时无中重度神经发育损害的存活。
要点
- 研究对象为出生时无活力、有HIE风险的足月及晚期早产儿。
- 干预为脐带挤奶,对照为早断脐,采用整群随机交叉设计。
- 主要结局包括出生住院期间死亡或中重度HIE及2岁时无中重度神经发育损害的存活。
核心结论
- CORDMILK试验旨在提供关键证据,明确脐带挤奶能否改善晚期早产及足月无活力新生儿出生住院期间无中重度HIE的存活及2岁时无显著神经发育损害的存活。
研究设计与样本
- 多中心、整群随机、交叉对照试验,在印度七家中心开展,比较脐带挤奶与早断脐。
- 研究对象为出生时无活力的足月及晚期早产儿。
- 试验开始前各中心通过计算机生成的随机方案分配初始研究组,入组完成50%后经过2个月洗脱期切换至另一研究组。
- 研究设计有足够把握度评估出生住院期间死亡或中重度HIE的复合结局及2岁时无中重度神经发育损害的存活。
主要发现
- 未报告结果数据(研究方案)。
- 次要结局包括1岁时无中重度神经发育损害的存活及出生住院期间MRI无脑损伤证据的存活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Facilitating placental transfusion-the transfer of blood from the placenta to the newborn-via delayed cord clamping (DCC) or umbilical cord milking (UCM) at birth has been shown to improve iron stores in healthy term infants and may positively impact long-term neurodevelopmental outcomes. Infants who are non-vigorous at birth and at risk of developing hypoxic-ischemic encephalopathy (HIE) are particularly likely to benefit from placental transfusion. This process may offer neuroprotection by enhancing cardiopulmonary transition, supporting cardiac preload, improving systemic and cerebral perfusion, delivering stem cells and neurotrophic factors, and preventing iron deficiency. While DCC is not currently recommended for non-vigorous term infants requiring immediate resuscitation, UCM offers a viable alternative, as it can be performed quickly. METHODS: This study is a multicenter, cluster-randomized, crossover-controlled trial comparing UCM with early cord clamping (ECC) in term and late preterm infants who are non-vigorous at birth. The trial will be conducted across seven centers in India. Before the trial begins, each site will be assigned to an initial study arm using a computer-generated randomization scheme. Once 50% of the enrollment is complete, sites will switch to the alternate study arm after a 2-month washout period. The study is designed with sufficient power to assess the composite outcome of death or moderate-to-severe HIE during birth hospitalization and survival without moderate-to-severe neurodevelopmental impairment at 2 years of age. Secondary outcomes include survival without moderate-to-severe neurodevelopmental impairment at 1 year of age and survival without evidence of brain injury on MRI during the birth hospitalization. DISCUSSION: The CORDMILK trial aims to generate critical evidence on whether UCM can improve survival without moderate-to-severe HIE during birth hospitalization and survival without significant neurodevelopmental impairment at 2 years of age in late preterm and term neonates who are non-vigorous at birth. TRIAL REGISTRATION: Clinical Trial Registry-India CTRI/2021/09/036759. Registered on 22/09/2021. CLINICALTRIALS: Gov number NCT03657394 and NCT03682042.
引用
- Yogeshkumar S, Vernekar SS, Dhaded SM, et al. CORDMILK: Umbilical Cord Milking versus Early Cord Clamping on short-and long-term outcomes in neonates who are non-vigorous at birth-study protocol of a multi-center, cluster-randomized, crossover-controlled trial. Trials. 2025. PMID: 41250198. doi:10.1186/s13063-025-09197-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。